Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Pharmacological reduction of reverse-translated hippocampal hyperactivity in mouse: relevance for psychosis
    Published on 2025-02-26
    1 year ago
  • Longitudinal associations between white matter integrity, early life adversities, and treatment response following cognitive-behavioral therapy in depression
    Published on 2025-02-25
    1 year ago
  • Protein interacting with C-kinase 1 (PICK1) regulates synaptic function and reversal learning in a mouse model for schizophrenia
    Published on 2025-02-21
    1 year ago
  • Prediction of alcohol intake patterns with olfactory and gustatory brain connectivity networks
    Published on 2025-02-16
    1 year ago
  • REM density predicts rapid antidepressant response to ketamine in individuals with treatment-resistant depression
    Published on 2025-02-14
    1 year ago
  • Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records
    Published on 2025-02-13
    1 year ago
  • Frontostriatal regulation of brain circuits contributes to flexible decision making
    Published on 2025-02-13
    1 year ago
« Previous 1 … 53 54 55 56 57 … 143 Next »
Journal of Psychopharmacology
  • Clinical quandaries in psychotic disorders: the road is long, with many a winding turn
    Published on 2023-10-16
    3 years ago
  • Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats
    Published on 2023-10-16
    3 years ago
  • Second International Consensus Study of Antipsychotic Dosing (ICSAD-2)
    Published on 2023-10-16
    3 years ago
  • Alterations of auditory sensory gating in mice with noise-induced tinnitus treated with nicotine and cannabis extract
    Published on 2023-10-14
    3 years ago
  • Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies
    Published on 2023-10-09
    3 years ago
  • Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial
    Published on 2023-09-23
    3 years ago
  • Comparative efficacy of quetiapine by dose and formulation for psychosis in schizophrenia: A systematic review and dose–response model-based network meta-analysis
    Published on 2023-09-23
    3 years ago
« Previous 1 … 53 54 55 56 57 … 145 Next »
European Neuropsychopharmacology
  • A posterior-alpha ageing network is differentially associated with antidepressant effects of venlafaxine and rTMS
    Published on 2023-11-25
    3 years ago
  • The significance of an integrated multi-omics approach in psychiatric disorders: A pharmacological perspective
    Published on 2023-11-16
    3 years ago
  • Substance P, NPY, CCK and their receptors in five brain regions in major depressive disorder with transcriptomic analysis of locus coeruleus neurons
    Published on 2023-11-05
    3 years ago
  • Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study
    Published on 2023-10-31
    3 years ago
  • Pro-social and pro-cognitive effects of LIT-001, a novel oxytocin receptor agonist in a neurodevelopmental model of schizophrenia
    Published on 2023-10-21
    3 years ago
  • Infection-associated chronic disability: A transdiagnostic and translational opportunity for neuroscience
    Published on 2023-10-20
    3 years ago
  • Do epidemiologists choose the right tools to explore the impact of mental disorders over time?
    Published on 2023-10-20
    3 years ago
« Previous 1 … 53 54 55 56 57 … 166 Next »

   Pharma Pub